Thus, IFNα-based immunotherapy is probably one of the only trigger factors of depression that is characterized by transition from an acute inflammatory state (accompanied by sickness behavior) to a chronic inflammatory state (accompanied by depression). The gene discussed is IFNA1; the disease is depressive disorder.